Imaging-Defined Radionecrosis After Stereotactic Radiosurgery in the Setting of Immune Checkpoint Inhibitors-A Cause for Alarm or a Harbinger of Enhanced Antitumor Immunity?
World Neurosurg. 2023 Jun 19:S1878-8750(23)00822-7.
doi: 10.1016/j.wneu.2023.06.054.
Online ahead of print.
1 Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
2 Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia, USA.
3 Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, USA.
4 Department of Medical Oncology, Miami Cancer Institute, Miami, Florida, USA; Department of Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, USA.